Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014–2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2022-03-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/28/3/21-1496_article |
| _version_ | 1828882513390469120 |
|---|---|
| author | Daniela Manno Philip Ayieko David Ishola Muhammed O. Afolabi Baimba Rogers Frank Baiden Alimamy Serry-Bangura Osman M. Bah Brian Köhn Ibrahim Swaray Kwabena Owusu-Kyei Godfrey T. Otieno Dickens Kowuor Daniel Tindanbil Elizabeth Smout Cynthia Robinson Babajide Keshinro Julie Foster Katherine Gallagher Brett Lowe Macaya Douoguih Bailah Leigh Brian Greenwood Deborah Watson-Jones |
| author_facet | Daniela Manno Philip Ayieko David Ishola Muhammed O. Afolabi Baimba Rogers Frank Baiden Alimamy Serry-Bangura Osman M. Bah Brian Köhn Ibrahim Swaray Kwabena Owusu-Kyei Godfrey T. Otieno Dickens Kowuor Daniel Tindanbil Elizabeth Smout Cynthia Robinson Babajide Keshinro Julie Foster Katherine Gallagher Brett Lowe Macaya Douoguih Bailah Leigh Brian Greenwood Deborah Watson-Jones |
| author_sort | Daniela Manno |
| collection | DOAJ |
| description |
We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014–2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.
|
| first_indexed | 2024-12-13T10:29:53Z |
| format | Article |
| id | doaj.art-2254071766d6435e89e08cf0d179f013 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-13T10:29:53Z |
| publishDate | 2022-03-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-2254071766d6435e89e08cf0d179f0132022-12-21T23:50:53ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592022-03-0128373473810.3201/eid2803.211496Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra LeoneDaniela MannoPhilip AyiekoDavid IsholaMuhammed O. AfolabiBaimba RogersFrank BaidenAlimamy Serry-BanguraOsman M. BahBrian KöhnIbrahim SwarayKwabena Owusu-KyeiGodfrey T. OtienoDickens KowuorDaniel TindanbilElizabeth SmoutCynthia RobinsonBabajide KeshinroJulie FosterKatherine GallagherBrett LoweMacaya DouoguihBailah LeighBrian GreenwoodDeborah Watson-Jones We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014–2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age. https://wwwnc.cdc.gov/eid/article/28/3/21-1496_articleEbola virusviruseszoonosesIgGantibodiesseroprevalence |
| spellingShingle | Daniela Manno Philip Ayieko David Ishola Muhammed O. Afolabi Baimba Rogers Frank Baiden Alimamy Serry-Bangura Osman M. Bah Brian Köhn Ibrahim Swaray Kwabena Owusu-Kyei Godfrey T. Otieno Dickens Kowuor Daniel Tindanbil Elizabeth Smout Cynthia Robinson Babajide Keshinro Julie Foster Katherine Gallagher Brett Lowe Macaya Douoguih Bailah Leigh Brian Greenwood Deborah Watson-Jones Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone Emerging Infectious Diseases Ebola virus viruses zoonoses IgG antibodies seroprevalence |
| title | Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone |
| title_full | Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone |
| title_fullStr | Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone |
| title_full_unstemmed | Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone |
| title_short | Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone |
| title_sort | ebola virus glycoprotein igg seroprevalence in community previously affected by ebola sierra leone |
| topic | Ebola virus viruses zoonoses IgG antibodies seroprevalence |
| url | https://wwwnc.cdc.gov/eid/article/28/3/21-1496_article |
| work_keys_str_mv | AT danielamanno ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT philipayieko ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT davidishola ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT muhammedoafolabi ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT baimbarogers ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT frankbaiden ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT alimamyserrybangura ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT osmanmbah ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT briankohn ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT ibrahimswaray ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT kwabenaowusukyei ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT godfreytotieno ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT dickenskowuor ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT danieltindanbil ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT elizabethsmout ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT cynthiarobinson ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT babajidekeshinro ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT juliefoster ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT katherinegallagher ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT brettlowe ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT macayadouoguih ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT bailahleigh ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT briangreenwood ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone AT deborahwatsonjones ebolavirusglycoproteiniggseroprevalenceincommunitypreviouslyaffectedbyebolasierraleone |